Fluzole


Project Description

Prevention of fungal infection in patients with malignancy following cytotoxic chemotherapy and in other immunocompromised patients

  1. Vaginal Candidiasis
  2. Mucosal and Systemic Candidiasis
  3. Cryptococcal Meningitis
  4. Oropharyngeal and Oesophageal Candidiasis
  5. Sporotrichosis
  6. Histoplasmosis

NAFDAC REG NO:

Dosage:

Oropharyngeal and Oesophageal Candidiasis: (Adult) Start 200mg followed by 100mg per day for 30 days.
Mucosal and Systemic Candidiasis: (Adult) Start 400mg followed by 200mg per day for 28 days.
Vaginal Candidiasis: (Adult) A single oral dose of 150mg.
Immunocompromised Patients: (Adult) 50 – 100mg daily.
Dosage in Children: 6mg/kg followed by 3mg/kg once daily for two weeks.